The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma
Z He, R Chen, S Hu, Y Zhang, Y Liu, C Li, F Lv, Z Xiao - BMC cancer, 2022 - Springer
Background To investigate the differences in HPV genotypes and clinical indicators between
cervical squamous cell carcinoma and adenocarcinoma and to identify independent …
cervical squamous cell carcinoma and adenocarcinoma and to identify independent …
Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma
T Murakami, Y Shoji, T Nishi, SC Chang… - Molecular …, 2021 - Wiley Online Library
Resistance to standard cisplatin‐based chemotherapies leads to worse survival outcomes
for patients with esophageal squamous cell carcinoma (ESCC). Therefore, there is an urgent …
for patients with esophageal squamous cell carcinoma (ESCC). Therefore, there is an urgent …
Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide …
Background Although neoadjuvant treatment (NAT) has become the standard of care for
patients with locally advanced esophageal cancer, the risk of recurrence remains high. The …
patients with locally advanced esophageal cancer, the risk of recurrence remains high. The …
Development and validation of a predictive model of therapeutic effect in patients with esophageal squamous cell carcinoma who received neoadjuvant treatment: a …
Background Neoadjuvant treatment has become the standard of care for patients with
advanced esophageal cancer. However, few studies have elucidated the clinical factors that …
advanced esophageal cancer. However, few studies have elucidated the clinical factors that …
Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer
XD Huang, LQ Huo, YS Luo, K Chen… - Therapeutic …, 2023 - journals.sagepub.com
Background: To investigate the prognostic role of pretreatment squamous cell carcinoma
antigen (SCCA) in early-stage cervical cancer (CC). Methods: We enrolled 487 cases of …
antigen (SCCA) in early-stage cervical cancer (CC). Methods: We enrolled 487 cases of …
Clinical significance of serum squamous cell carcinoma antigen for patients with recurrent esophageal squamous cell carcinoma
Y Kanie, A Okamura, S Maruyama, K Sakamoto… - Annals of Surgical …, 2021 - Springer
Background Squamous cell carcinoma antigen (SCC-Ag) is a widely used tumor marker of
SCC. However, the clinical significance of serum SCC-Ag levels in recurrent esophageal …
SCC. However, the clinical significance of serum SCC-Ag levels in recurrent esophageal …
Indications for neoadjuvant chemotherapy in older patients undergoing esophagectomy for esophageal cancer
K Yamashita, K Momose, K Tanaka, T Makino, T Saito… - Surgery Today, 2024 - Springer
Purpose To investigate the indications for neoadjuvant chemotherapy (NAC) in esophageal
cancer patients aged 75 years or older. Methods We analyzed data, retrospectively, from …
cancer patients aged 75 years or older. Methods We analyzed data, retrospectively, from …
Clinical features and risk factors for early recurrence after esophagectomy following neoadjuvant chemotherapy for esophageal cancer
T Kurogochi, M Honda, K Takahashi, A Okamura… - Surgery Today, 2022 - Springer
Purpose The purpose of this study was to clarify the clinical features and outcomes of
patients with recurrence after esophagectomy following neoadjuvant chemotherapy (NAC) …
patients with recurrence after esophagectomy following neoadjuvant chemotherapy (NAC) …
[HTML][HTML] Expression changes and clinical significance of serum neuron-specific enolase and squamous cell carcinoma antigen in lung cancer patients after …
L Sun, Q Shao - Clinics, 2023 - SciELO Brasil
Objective: To explore the changes and clinical significance of serum Neuron-Specific
Enolase (NSE) and Squamous Cell Carcinoma antigen (SCC) in patients with lung cancer …
Enolase (NSE) and Squamous Cell Carcinoma antigen (SCC) in patients with lung cancer …
Nomograms to predict tumor regression grade (TRG) and ypTNM staging in patients with locally advanced esophageal cancer receiving neoadjuvant therapy
J Qiu, Z Zhang, J Liu, Y Zhao, Y Li, Z Tang, L Li… - World Journal of …, 2024 - Springer
Background Neoadjuvant therapy (NT) has increased survival rates for patients with locally
advanced esophageal cancer (EC), but estimating the impact of NT treatment prior to …
advanced esophageal cancer (EC), but estimating the impact of NT treatment prior to …